$PBYI News

Puma Biotechnology, Inc. 2026 Q2 - Results - Earnings Call Presentation

TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

Puma Biotechnology, Inc. (PBYI) Q2 2026 Earnings Call Transcript

Puma Biotechnology (NASDAQ:PBYI) Beats Q2 Estimates, but Soft Q3 Guidance Tempers Reaction

Puma Biotechnology Sees Q3 Sales $56.000M-$59.000M vs $60.500M Est

Puma Biotechnology Raises FY2026 Sales Guidance from $222.000M-$229.000M to $224.000M-$231.000M vs $222.000M Est

Puma Biotechnology Q2 Adj. EPS $0.19 Beats $0.04 Estimate, Sales $53.600M Beat $53.000M Estimate

Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Puma (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology Q1 Earnings Call Highlights

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology, Inc. Q1 2026 Earnings Call Summary

Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation

PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance

Puma Biotechnology Reports First Quarter 2026 Financial Results

Puma Biotechnology Sees Q2 Sales $52.000M-$55.000M vs $52.000M Est